GAVISCON MENTHE, chewable tablet 20 tablets
Active ingredients: Sodium alginate, Sodium bicarbonate, Calcium carbonate
Commercialized according to BDPM
Chewable tablet20 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- GAVISCON MENTHE, comprimé à croquer
- Pharmaceutical form
- comprimé à croquer
- Route of administration
- orale
- Presentation description
- 1 pilulier(s) polypropylène de 20 comprimé(s)
- Marketing authorisation holder
- RECKITT BENCKISER HEALTHCARE FRANCE
- Reimbursement according to BDPM
- 15%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 Jan 2024
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67557241CIP73679096CIP133400936790964Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CARBONATE DE CALCIUMcomprimé | 160 mg · un comprimé | SA |
| BICARBONATE DE SODIUMcomprimé | 267 mg · un comprimé | SA |
| ALGINATE DE SODIUMcomprimé | 500 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.